GlaxoSmithKline Bangladesh Ltd. announced earnings results for the third quarter ended September 30, 2019. For the third quarter, the company announced sales was BDT 1,120.145 million compared to BDT 1,206.871 million a year ago. Operating income was BDT 333.362 million compared to BDT 366.093 million a year ago. Net income was BDT 254.670 million compared to net loss of BDT 585.909 million a year ago. Basic earnings per share from continuing operations was BDT 22.51 compared to BDT 38.8 a year ago. Basic earnings per share was BDT 21.14 compared to basic loss per share of BDT 48.64 a year ago. For the nine months, sales was BDT 3,437.127 million compared to BDT 3,540.887 million a year ago. Operating income was BDT 723.993 million compared to BDT 678.760 million a year ago. Net income was BDT 522.716 million compared to net loss of BDT 403.516 million a year ago. Basic earnings per share from continuing operations was BDT 51.04 compared to BDT 61.22 a year ago. Basic earnings per share was BDT 43.39 compared to basic loss per share of BDT 33.5 a year ago.